龙虎榜数据显示，该股因连续3个交易日内日收盘价格涨幅偏离值累计达30%、日换手率达30%上榜龙 虎榜2次，买卖居前营业部中，机构净买入4305.74万元，营业部席位合计净卖出1368.79万元。（数据 宝） | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2026.01.07 | -11.11 | 44.91 | -7370.44 | | 2026.01.06 | 20.00 | 17.90 | 7057.72 | | 2026.01.05 | 20.00 | 21.38 | 15640.44 | | 2025.12.31 | -1.00 | 4.22 | -821.14 | | 2025.12.30 | -2.98 | 7.44 | -1537.45 | | 2025.12.29 | 1.80 | 10.77 | 1361.34 | | 2025.12.26 | -1.29 | 6.77 | -530.62 | | 2025.12.25 | 3.34 | 13.54 | -735.59 | | 2025.12.24 | ...

Group 1 - The core viewpoint of the article highlights a significant surge in A-share market stocks related to brain-computer interface (BCI) technology, driven by recent developments in the sector [1] - Aipeng Medical reached a 20% daily limit increase, while Kefu Medical rose over 15%, indicating strong investor interest in BCI-related companies [1] - Notable stocks such as Nanjing Panda, Pulite, and Innovation Medical achieved a 10% daily limit increase, reflecting a broader trend of positive market sentiment towards BCI stocks [1] Group 2 - The article mentions that on January 6, Strong Brain Technology, a leading company in the BCI field, announced the completion of approximately 2 billion RMB in financing, marking a significant milestone for the industry [1] - This financing round is noted to be the second largest globally in the BCI sector, only behind Neuralink, which is owned by Elon Musk [1] - The financing success of Strong Brain Technology is expected to further stimulate interest and investment in the BCI market, potentially leading to more advancements and innovations in the field [1]

脑机接口板块持续走强，爱朋医疗20cm涨停创新高，南京熊猫此前涨停录得4连板，创新医疗、岩山科 技、塞力医疗涨幅居前。 ...

Core Viewpoint - The ChiNext Index rose by 0.31% to close at 3329.69 points, with a total trading volume of 763.25 billion yuan, a decrease of 0.225 billion yuan from the previous trading day [1] Trading Performance - Among the 581 tradable stocks on the ChiNext, 581 stocks closed higher, with 24 stocks rising over 10%, including Gao Meng New Materials, Huarong Chemical, and Meihua Medical, which all hit the daily limit [1] - 794 stocks closed lower, with 4 stocks declining over 10%, including Rongke Technology, which hit the daily limit down [1] Turnover Rate - The average turnover rate for the ChiNext today was 5.16%, with 58 stocks having a turnover rate exceeding 20% [1] - The highest turnover rate was for C Xin Guangyi at 65.38%, with a closing price of 74.58 yuan and a trading volume of 1.509 billion yuan [1][4] - Other notable stocks with high turnover rates included Shaoyang Hydraulic (48.99%), Sanbo Brain Science (46.31%), and Aipeng Medical (44.91%) [1][4] Institutional Activity - Eight high-turnover stocks appeared on the Dragon and Tiger list, with institutional participation noted in several stocks [3] - Sanbo Brain Science had 4 institutional seats with a net buy of 266 million yuan, while Gao Meng New Materials also had 4 institutional seats with a net buy of 161 million yuan [3] Capital Flow - Among high-turnover stocks, 34 experienced net inflows from main funds, with significant inflows into Nanda Optoelectronics (871 million yuan), Dongfang Risheng (531 million yuan), and Xinwei Communication (394 million yuan) [4] - Conversely, Sanbo Brain Science, Blue Focus, and Huali Chuantong saw the largest net outflows, amounting to 685 million yuan, 631 million yuan, and 569 million yuan, respectively [4] Earnings Forecast - Three high-turnover stocks released earnings forecasts for 2025, all indicating profit growth [4] - Tian Su Measurement is expected to have the highest net profit growth rate at 10.31%, followed by C Xin Guangyi and Nabai Chuan with growth rates of 10.00% and 9.72%, respectively [4]

Market Overview - The three major A-share indices experienced slight increases, with the Shanghai Composite Index rising by 0.05% to 4085 points, the Shenzhen Component Index increasing by 0.06%, and the ChiNext Index up by 0.31% [1][2] - The total market turnover reached 2.88 trillion yuan, an increase of 49.3 billion yuan compared to the previous trading day, with nearly 3200 stocks declining [1] Index Performance - Shanghai Composite Index: 4085.77 (+2.11, +0.05%) [2] - Shenzhen Component Index: 14030.56 (+8.01, +0.06%) [2] - ChiNext Index: 3329.69 (+10.40, +0.31%) [2] - Sci-Tech 50 Index: 1443.39 (+14.09, +0.99%) [2] - CSI 300 Index: 4776.67 (-14.03, -0.29%) [2] - CSI 500 Index: 7875.08 (+60.95, +0.78%) [2] Sector Performance - The storage chip sector saw a significant surge, with companies like Tongcheng New Materials and Hengkun New Materials hitting the daily limit [1][3] - The electronic chemicals sector also rose, with Guanggang Gas hitting the daily limit [1][3] - The photolithography machine sector strengthened, with companies like Nanda Optoelectronics reaching the daily limit [1][3] - The media sector experienced gains, with companies such as Dayou Energy and Shanxi Black Cat hitting the daily limit [3] Declining Sectors - The DRG/DIP concept saw a decline, with Rongke Technology hitting a 20% limit down [3] - The brain-computer interface sector faced a significant pullback, with companies like Chengyitong and Aipeng Medical dropping over 10% [3] - The titanium dioxide sector weakened, with Zhenhua Co. leading the decline [3] - Sectors related to digital currency, under-screen photography, and brokerage concepts also experienced notable declines [3]

Market Overview - On January 6, the A-share market experienced a broad-based rally, with the Shanghai Composite Index rising by 1.50% to close at 4083.67 points, and the Shenzhen Component Index increasing by 1.40% to 14022.55 points. The total trading volume in the Shanghai and Shenzhen markets reached 2.81 trillion yuan, significantly higher than the previous trading day [1][14]. - The market showed a balanced performance in terms of individual stocks, with 2371 stocks experiencing net inflows from large orders, while 2538 stocks saw net outflows. There was a clear trend of funds concentrating on high-growth sectors and undervalued stocks, indicating significant sector rotation [1][14]. Sector Performance - The non-bank financial sector was the strongest performer, with a net inflow of 6.437 billion yuan and a sector index increase of 3.73%. The metals sector followed closely, rising by 4.26% with a net inflow of 3.663 billion yuan. Other active sectors included optical electronics, chemical raw materials, and minor metals, which also saw significant inflows [1][14]. - Conversely, the telecommunications sector faced substantial outflows, with a net outflow of 7.564 billion yuan. Other sectors such as media, machinery equipment, and pharmaceutical biology also experienced net outflows, indicating a clear adjustment trend [1][14]. Investment Opportunities - **Binhu Chemical (601678)**: A leading chemical company with a focus on low valuation and industry upgrades. The stock hit the daily limit on January 6, closing at 4.75 yuan, with a five-day increase of 10.72%. The company is advancing green low-carbon industrial park construction and digital upgrades, indicating strong valuation recovery potential [2][3]. - **Jiahua Energy (600273)**: A quality energy chemical stock with a complete industrial chain. The stock also hit the daily limit on January 6, closing at 9.59 yuan, with a five-day increase of 14.44%. The company's performance is supported by steady growth and low valuation [4][5]. - **Rainbow Technology (600707)**: A leader in display panels, the stock closed at 7.05 yuan on January 6, with a five-day increase of 12.44%. The company is optimizing its business structure through collaboration with BOE, enhancing its growth prospects [6][7]. Risks in High Valuation Stocks - **International Medical (000516)**: A medical service stock that has shown two consecutive limit-ups but has a significant valuation bubble. The stock closed at 5.19 yuan on January 6, with a five-day increase of 15.59%. The company reported losses, indicating a lack of fundamental support [8][9]. - **Guosheng Technology (603778)**: A new energy stock that has also shown two consecutive limit-ups but lacks performance support. The stock closed at 21.3 yuan on January 6, with a five-day increase of 34.05%. The company continues to report losses, leading to a significant valuation bubble [10][11]. - **Aipeng Medical (300753)**: A medical device stock with high valuation premiums, closing at 39.96 yuan on January 6, with a five-day increase of 38.99%. The company has reported losses, and its stock price is driven by speculative trading rather than fundamental improvements [12][13]. Summary and Investment Strategy - The A-share market is showing a broad rally with significant trading activity, particularly in sectors with clear industrial logic and strong performance certainty. Companies like Binhu Chemical, Jiahua Energy, and Rainbow Technology are highlighted as undervalued opportunities with clear recovery potential [14][15]. - In contrast, stocks like International Medical, Guosheng Technology, and Aipeng Medical are identified as high-risk due to their reliance on speculative trading and lack of fundamental support. Investors are advised to focus on sectors with strong performance certainty while avoiding high-premium stocks lacking earnings support [14][15].

（文章来源：证券时报网） 数据宝统计，截至14:24，爱朋医疗成交额13.25亿元，创2025年6月19日以来新高。最新股价下跌 9.53%，换手率40.83%。上一交易日该股全天成交额为6.19亿元。（数据宝） ...

| 代码 | 名称 | | 涨幅% ↑ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | --- | | 688273 | 麦澜德 | 1 | -11.09 | 54.43 乙 | 28.01 | | 300430 | 诚益通 | 1 | -10.91 | 67.31亿 | 28.25 | | 301330 | 熵基科技 | 1 | -10.40 | 100亿 | 29.02 | | 300753 | 爰朋医疗 | 1 | -10.39 | 45.14亿 | 29.05 | | 300652 | 雷迪克 | 中 | -8.34 | 82.53 Z | 12.78 | | 688580 | 伟思医疗 | 1 | -8.03 | 61.39亿 | 32.44 | | 603579 | 荣泰健康 | 1 | -6.80 | 54.60亿 | 12.77 | | 301087 | 可孚医疗 | 1 | -6.44 | 99.25亿 | 6.36 | | 300884 | 狄耐克 | 1 | -6.19 | 42.34亿 | 12.70 | | 603610 | 麒盛科 ...

消息面上，多家脑机接口概念股出降温公告。其中，航天长峰称公司未实际开展脑机接口等相关业务； 伟思医疗称在脑机接口领域的新产品仍处于市场培育初期。 格隆汇1月7日｜A股市场部分脑机接口概念股明显回调，其中，麦澜德、熵基科技跌超10%，诚益通、 雷迪克跌超7%，博拓生物、爱朋医疗跌超6%，可孚医疗、翔宇医疗跌超5%，狄耐克、伟思医疗跌超 4%。 股票频道更多独家策划、专家专栏，免费查阅>> 责任编辑：栎树 ...

Group 1 - The A-share market has seen a significant pullback in brain-computer interface (BCI) concept stocks, with notable declines in companies such as Mailland and Entropy Technology, which fell over 10% [1] - Several BCI concept stocks have issued announcements indicating a cooling off, with Aerospace Changfeng stating that it has not actually engaged in BCI-related business [1] - Weisi Medical mentioned that its new products in the BCI field are still in the early stages of market cultivation [1] Group 2 - Specific stock performance includes Mailland down 10.68% with a market cap of 5.468 billion, Entropy Technology down 10.13% with a market cap of 10.1 billion, and Chengyi Tong down 7.55% with a market cap of 6.985 billion [2] - Other notable declines include Leedick down 7.14%, Botao Biological down 6.37%, and Aipeng Medical down 6.38% [2] - The overall trend shows that many BCI-related stocks are experiencing a downturn, with declines ranging from 4.33% to 10.68% across various companies [2]